drugset / Trial / NCT00653744

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

NCT00653744

Phase 3 Completed 1700 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in African American subjects with hypercholesterolemia.

Timeline

Start
2002-03
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule
Subject Rosuvastatin Small molecule

Indications